Streetbeat News

Earnings

ZS

Zscaler reported strong Q4 2024 results, with adjusted EPS of $0.88 beating estimates by 27.54% and sales of $592.9M surpassing expectations by 4.40%. This marks a 30.31% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:06 pm

HQY

HealthEquity has provided its financial guidance for fiscal year 2025, projecting adjusted earnings per share (EPS) between $2.98 and $3.14, and revenues between $1.165 billion and $1.185 billion.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:05 pm

HQY

HealthEquity reported strong Q2 2025 results, with adjusted EPS of $0.86 beating estimates by 22.86% and sales of $299.928M surpassing expectations by 5.29%. This marks a 23.15% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:04 pm

COIN

DIS

MCD

NVDA

Nvidia's stock has seen a significant decline since its Q2 earnings report, losing $413.1 billion in market capitalization, more than the combined value of McDonald's, Disney, and Coinbase. Despite beating earnings and revenue estimates, the stock fell due to concerns over slowing growth rates and margins. Analysts have mixed views, with some seeing the dip as a buying opportunity. Nvidia's stock is still up 126% year-to-date.

Portfolio Pulse from Chris Katje

September 03, 2024 | 8:01 pm

ADM

ADM's ethanol margins improved in the third quarter, as announced by the CEO at a Barclays conference.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 7:58 pm

GME

GameStop (NYSE:GME) shares are rising due to several recent developments. The company terminated a $250 million credit facility with Wells Fargo, is converting locations to retro gaming stores, and will release Q2 financial results on Sept. 10. Analysts expect a loss of 9 cents per share and $895.67 million in revenue. GME stock is up 11% over the past five days.

Portfolio Pulse from Erica Kollmann

September 03, 2024 | 7:39 pm

AI

C3.ai Inc (NYSE:AI) is set to report its Q1 earnings, with analysts expecting revenue of $86.9 million and a loss of 13 cents per share. The company has a history of beating EPS estimates and is diversifying into new AI sectors. Investors will watch for updates on its deal pipeline and federal agreements.

Portfolio Pulse from Chris Katje

September 03, 2024 | 7:29 pm

TEVA

Teva Pharmaceutical Indus (NYSE:TEVA) has received mixed analyst ratings, with a recent trend towards bullish perspectives. Analysts have set a 12-month average price target of $23.75, reflecting a 10.47% increase from the previous target. Despite positive revenue growth, Teva faces challenges with profitability and returns, as indicated by below-average net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 7:01 pm

LXRX

Lexicon Pharmaceuticals (NASDAQ:LXRX) has received 8 analyst ratings in the past three months, all of which are bullish. The average 12-month price target is $10.00, with no changes in recent months. The company has shown significant revenue growth but struggles with profitability, as indicated by its negative net margin and ROA. However, it maintains a strong ROE and a sound debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 7:00 pm

DIVL

FCFY

FCLD

FOVL

HPE

KNGZ

Hewlett Packard Enterprise (HPE) is expected to perform well in its upcoming Q3 earnings report due to strong AI demand, recovery in infrastructure, and networking equipment demand. JPMorgan forecasts higher-than-consensus revenue and EPS for HPE, indicating potential upward revisions. HPE's stock is trading at a low multiple, making it attractive to investors.

Portfolio Pulse from Michael Juliano

September 03, 2024 | 6:44 pm